"There's a concern that
costs could go up in 2021 due to the deferral of services, while perhaps risk
scores might go down in 2021 due to the inability to meet with beneficiaries
and capture their 2020 diagnoses, and that obviously creates a challenging situation
for the health plans next year."
— Brad Piper, a principal and consulting actuary with the
Milwaukee office of Milliman, Inc., spoke with AIS’s RADAR on Medicare Advantage
about the cost-related unknowns Medicare Advantage plans will face in 2021, in
the wake of the COVID-19 pandemic.
No comments:
Post a Comment